Stock listing
NASDAQ:ARNA Arena Pharmaceuticals Inc Stock
Follow Arena Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ARNA
$99.99 USD
Close on Mar 10, 2022 · No longer trades
- Lowest – highest close
- $14.03 – $99.99 USDSince Jun 19, 2017 · lowest Jun 19, 2017 · highest Mar 10, 2022
Delisted NASDAQ:ARNA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ARNA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Arena Pharmaceuticals Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Nov 4, 2021
- Decks
- 16 decks · latest Dec 14, 2021
Events
| Call | When | Status |
|---|---|---|
| Arena Pharmaceuticals (ARNA) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 4:30 PM ET | Replay |
| Arena Pharmaceuticals (ARNA) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 4:30 PM ET | Replay |
| Arena Pharmaceuticals (ARNA) Q1 2021 Earnings Call | Wed, May 05, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (December 2021) | Merger or acquisition | 14 slides | Dec 14, 2021 |
| Merger or Acquisition (December 2021) | Merger or acquisition | 9 slides | Dec 13, 2021 |
| Investor Presentation (January 2021) | Investor deck | 21 slides | Jan 11, 2021 |
| Investor Presentation (November 2020) | Investor deck | 35 slides | Nov 18, 2020 |
| Investor Presentation (October 2020) | Investor deck | 32 slides | Oct 26, 2020 |
| Corporate Update (September 2020) | Corporate update | 13 slides | Sep 23, 2020 |
| Investor Presentation (January 2020) | Investor deck | 44 slides | Jan 10, 2020 |
| Investor Presentation (January 2019) | Investor deck | 37 slides | Jan 7, 2019 |
| Investor Day (October 2018) | Investor day | 64 slides | Oct 4, 2018 |
| Investor Presentation (August 2018) | Investor deck | 33 slides | Aug 9, 2018 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (March 2018) | Technical | 23 slides | Mar 19, 2018 |
| Investor Presentation (February 2018) | Investor deck | 27 slides | Feb 15, 2018 |
| J.P. Morgan Healthcare Conference 2018 | Conference | 26 slides | Jan 5, 2018 |
| Technical Presentation (July 2017) | Technical | 13 slides | Jul 10, 2017 |
| JP Morgan Healthcare Conference 2017 | Conference | 28 slides | Jan 6, 2017 |
| Shareholder Meeting (June 2016) | Shareholder meeting | 7 slides | Jun 10, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Louis J Lavigne Jr Other companies: Alector, Inc. (Director · Since at least Feb 6, 2019); DocuSign, Inc. (Director · Apr 26, 2018 – Jun 17, 2019 · Past); NovoCure Limited (Director · Oct 1, 2015 – May 31, 2017 · Past); Zynga Inc (Director · Apr 23, 2015 – May 23, 2022 · Past); Depomed Inc (Director · Jul 6, 2013 – May 8, 2018 · Past); Accuray Incorporated (Director · Sep 4, 2009 – Nov 30, 2020 · Past); BMC Software Inc (Director · Aug 22, 2006 – Sep 10, 2013 · Past); Kyphon Inc (Director · Jul 31, 2006 – Nov 2, 2007 · Past); Equinix, Inc. (Director · Jun 8, 2006 – Jun 8, 2006 · Past) | Director · Jul 28, 2006 – Jul 28, 2006 · Past |
| Tina Susan Nova Other companies: Aurinia Pharmaceuticals Inc (Director · Since at least May 15, 2025); Azenta, Inc. (Director · Since at least Feb 3, 2023); Exagen Inc. (Director · Since at least Sep 18, 2019); CapForce Inc. (Director · Apr 24, 2017 – Sep 2, 2019 · Past); Veracyte, Inc. (President, CLIA U.S. · Nov 12, 2015 – Mar 3, 2022 · Past); NanoString Technologies Inc (Director · Apr 29, 2014 – Apr 29, 2014 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past); Genoptix Inc (President and CEO, Director · Oct 29, 2007 – Mar 7, 2011 · Past); Cypress Bioscience Inc (Director · Apr 26, 2007 – Jan 4, 2010 · Past) | Director · Jul 28, 2006 – Mar 11, 2022 · Past |
| Manmeet Soni Other companies: Summit Therapeutics Inc. (Chief Operating Officer, Chief Financial Officer & Director · Since at least Sep 18, 2020); Pulse Biosciences, Inc (Director · Since at least Nov 2, 2017); Reata Pharmaceuticals Inc (COO, CFO and President · Aug 28, 2019 – Sep 26, 2023 · Past); Alnylam Pharmaceuticals, Inc. (Chief Financial Officer · May 9, 2017 – Feb 28, 2019 · Past); Ariad Pharmaceuticals Inc (EVP, CFO & Treasurer · Mar 21, 2016 – Feb 16, 2017 · Past); Pharmacyclics Inc (Chief Financial Officer · Feb 13, 2013 – May 26, 2015 · Past) | Director · Dec 14, 2018 – Jun 17, 2020 · Past |
| Preston Klassen Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Histogen Inc (Director · Feb 7, 2014 – Jun 27, 2019 · Past); Orexigen Therapeutics Inc (EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past) | EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past |
| Katharine Knobil Other companies: Korro Bio, Inc. (Director · Since at least Aug 26, 2024); Pliant Therapeutics, Inc. (Director · Since at least Sep 14, 2022); Marker Therapeutics, Inc. (Chief Medical Officer, Altesa BioSciences, Inc. · Since at least Dec 8, 2021); Kaleido Biosciences, Inc. (Chief Medical Officer · Feb 27, 2019 – Oct 15, 2020 · Past) | Director · Jun 12, 2020 – Mar 11, 2022 · Past |
| Jayson Donald Alexander Dallas Other companies: Damora Therapeutics, Inc. (Director · Since at least Nov 19, 2020); Aimmune Therapeutics Inc (President and CEO, Director · Jun 19, 2018 – Oct 10, 2020 · Past); Ultragenyx Pharmaceutical Inc. (EVP & Chief Commercial Officer · Aug 3, 2015 – Jun 1, 2018 · Past) | Director · Feb 13, 2017 – Mar 11, 2022 · Past |
| Kevin Lind Other companies: Apnimed, Inc. (Chief Executive Officer · Since at least Jul 30, 2026); Avalo Therapeutics, Inc. (Director · Since at least Sep 22, 2025); Longboard Pharmaceuticals Inc (President and CEO, Director · Mar 11, 2021 – Dec 2, 2024 · Past) | Executive VP and CFO · Jun 15, 2016 – Mar 1, 2020 · Past |
| Vincent Aurentz Other companies: Inhibikase Therapeutics, Inc. (Director · Since at least Feb 21, 2025); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); EPIRUS Biopharmaceuticals Inc (Chief Business Officer · Nov 9, 2015 – May 27, 2016 · Past) | Executive VP and CBO · Aug 15, 2016 – Mar 11, 2022 · Past |
| Robert Lisicki Other companies: Zura Bio Limited (Chief Executive Officer, Director · Jan 8, 2024 – Feb 27, 2025 · Past); Cadrenal Therapeutics, Inc. (Director · Jul 23, 2023 – Jan 23, 2025 · Past) | EVP, Chief Commercial Officer · Aug 4, 2020 – Mar 11, 2022 · Past |
| Dominic P Behan | EVP & Chief Scientific Officer, Director · Mar 19, 2012 – Mar 2, 2016 · Past |
All 15 people
| Person | Seat |
|---|---|
| Donald D Belcher | Director · Jun 13, 2016 – Jun 13, 2016 · Past |
| K A Ajit-Simh | Sr. VP, Quality & Reg Compl · Dec 30, 2005 – Mar 15, 2011 · Past |
| Louis J Scotti | VP, Marketing and Business Dev · Sep 26, 2007 – Mar 3, 2008 · Past |
| Randall E Woods | Director · Jun 13, 2019 – Nov 12, 2019 · Past |
| Scott H Bice | Director · Jul 28, 2006 – Jun 13, 2017 · Past |
Log in to ask 6ix AI your own questions about Arena Pharmaceuticals Inc.